Risk factors and prognosis in gestational trophoblastic neoplasia: A Review

Authors

DOI:

https://doi.org/10.33448/rsd-v12i9.43348

Keywords:

NTG; Pregnancy; Health; Risks.

Abstract

Risk factors and prognosis play a crucial role in the assessment and treatment of gestational trophoblastic neoplasia (NTG), a rare and potentially serious condition that affects placental tissue during pregnancy. It is noteworthy that understanding risk factors helps healthcare professionals identify pregnant women who may be at higher risk of developing NTG. This enables earlier diagnosis and, consequently, more effective treatment. In this study, the aim was to conduct a comprehensive review of the available scientific literature to identify key risk factors associated with NTG and assess prognostic factors that influence clinical outcomes and disease progression. This research is a systematic review, emphasizing that this is a rigorous and structured approach to synthesizing available scientific evidence on a specific research topic. After analysis, the search resulted in ten scientific articles that formed the basis of the research. The information reveals that advanced gestational age, previous experience with hydatidiform mole, a history of having children, and living far from healthcare centers were identified as factors that significantly increase the risk. From this analysis of factors influencing the likelihood of developing gestational trophoblastic neoplasia and variables impacting its clinical course, we can infer that having a deep understanding of these components plays an essential role in the assessment and effective treatment of this medical condition.

References

Al-Husaini, H., Soudy, H., Darwish, A., Ahmed, M., Eltigani, A. et al. (2015). Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience. Clinical and Translational Oncology, 17, 409-415.

Araújo, T. M. D., Araújo, M. F. M. D., Caetano, J. Á., Galvão, M. T. G., & Damasceno, M. M. C. (2011). Diagnósticos de enfermagem para pacientes em risco de desenvolver úlcera por pressão. Revista Brasileira de Enfermagem, 64, 671-676.

Berkowitz, R. S., Goldstein, D. P. (2013). Current advances in the management of gestational trophoblastic diseases. Gynecologic Oncology,128(1), 3-5

Biscaro, A., Braga, A., & Berkowitz, R. S. (2015). Diagnóstico, classificação e tratamento da neoplasia trofoblástica gestacional. Revista Brasileira de Ginecologia e Obstetrícia, 37, 42-51.

Clark, L. H., Staley, S. A., Barber, E. L., Wysham, W. Z., Kim, K. H., & Soper, J. T. (2016). The effect of distance traveled on disease outcomes in gestational trophoblastic neoplasia. American journal of obstetrics and gynecology, 215(2), 217-e1.

Clarke M, Horton R. (2001). Bringing it all together: Lancet-Cochrane collaborate on systematic reviews. Lancet, 2(357), 1728.

Couder, F., Massardier, J., You, B., Abbas, F., Hajri, T. et al. (2016). Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate alone. American Journal of Obstetrics and Gynecology, 215(1), 80-e1.

Dias, E. G., Santos, D. D. C., Dias, E. N. F., Alves, J. C. S., & Soares, L. R. (2015). Perfil socioeconômico e prática do exame de prevenção do câncer do colo do útero de mulheres de uma unidade de saúde. Revista Saúde e Desenvolvimento, 7(4), 135-146.

Ferraz, L., de Fátima Lopes, P., Ramos, C. A. B., Boechat, S. G., Fonseca, I. P., & Braga, A. (2021). Doença trofoblástica gestacional. Saber Científico (1982-792X), 7(1), 83-90.

França, A. C. G., Uberti, E. M. H., Muller, K. P., Cardoso, R. B., Giguer, F., Beitune, P. E., & Braga, A. (2022). Aspectos emocionais e clínicos observados em mulheres com doença trofoblástica gestacional: Uma ação multidisciplinar. Revista Brasileira de Ginecologia e Obstetrícia, 44, 343-351.

Jareemit, N., Horowitz, N. S., Goldstein, D. P., Berkowitz, R. S., & Elias, K. M. (2020). Outcomes for relapsed versus resistant low risk gestational trophoblastic neoplasia following single-agent chemotherapy. Gynecologic Oncology, 159(3), 751-757.

Karimi-Zarchi, M., Mortazavizadeh, M. R., Soltani-Gerdefaramrzi, M., Rouhi, M., Yardian-Anari, P., Ahmadiyeh, M. H. (2015). Investigation of Risk Factors, Stage and outcome in patients with Gestational trophoblastic disease since 2001 to 2011 in Iran-Yazd. Internacional Journal of Biomedical Science, 2(4)166-172.

Lima, L. D. L. A., Padron, L., Câmara, R., Sun, S. Y., Rezende, J., & Braga, A. (2017). Papel da cirurgia no manejo de mulheres com doença trofoblástica gestacional. Revista do Colégio Brasileiro de Cirurgiões, 44, 94-101.

Lurain, J. R. (2010). Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. American journal of obstetrics and gynecology, 203(6), 531-539.

Maestá, I., Moreira, M. D. F. S., Rezende-Filho, J., Bianconi, M. I., Jankilevich, G., et al. (2020). Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America. International Journal of Gynecologic Cancer, 30(9).

Matos, M., Ferraz, L., Lopes, P. D. F., Lozoya, C., Amim Junior, J., Rezende-Filho, J., & Braga, A. (2015). Neoplasia trofoblástica gestacional após normalização espontânea da gonadotrofina coriônica humana em paciente com mola hidatiforme parcial. Revista Brasileira de Ginecologia e Obstetrícia, 37, 339-343.

Mattos, A. C. G. B. F., Novais, D. F. F., Reis, G. B. R., da Silva Rocha, G. R., Prudêncio, M. C., & da Silva Reis, V. C. (2020). Diagnóstico, tratamento e seguimento da mola hidatiforme: uma revisão bibliográfica. Revista Eletrônica Acervo Científico, 13, e5184-e5184.

Ngan, H. Y., Kohorn, E. I., Cole, L. A., Kurman, R. J, Kim, S. J., Lurain, J. R. et al. (2012). Trophoblastic disease. Internacional Journal of Gynecology and Obstetrics,119(2), 130-136.

Ramírez, L. A. C., Maestá, I., Bianconi, M. I., Jankilevich, G., Otero, S. et al. (2022). Clinical Presentation, Treatment Outcomes, and Resistance-related Factors in South American Women with Low-risk Postmolar Gestational Trophoblastic Neoplasia. Revista Brasileira de Ginecologia e Obstetrícia, 44, 746-754.

Segura Munoz, S. I., Takayanagui, A. M. M., & Santos, C. B. D. (2002). Revisão sistemática de literatura e metanálise: noções básicas sobre seu desenho, interpretação e aplicação na área da saúde. In Proceedings of the 8. Brazilian Nursing Communication Symposium.

Published

27/09/2023

How to Cite

CARVALHO, A. R. de M. L. .; SERRA, I. G. S. S. . Risk factors and prognosis in gestational trophoblastic neoplasia: A Review. Research, Society and Development, [S. l.], v. 12, n. 9, p. e13812943348, 2023. DOI: 10.33448/rsd-v12i9.43348. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/43348. Acesso em: 11 may. 2024.

Issue

Section

Health Sciences